###begin article-title 0
###xml 77 85 <span type="species:ncbi:9606">Patients</span>
Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism in Korean Patients with Systemic Sclerosis
###end article-title 0
###begin p 1
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
###xml 459 464 <span type="species:ncbi:9606">women</span>
###xml 534 542 <span type="species:ncbi:9606">patients</span>
###xml 681 689 <span type="species:ncbi:9606">patients</span>
To determine whether angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism is associated with the development and clinical features of systemic sclerosis (SSc) in Korean, we studied seventy two Korean patients with SSc fulfilling the ACR preliminary classification criteria. The controls were 114 healthy, disease free Koreans. ACE I/D genotypes were determined by PCR method using oligonucleotides. Sixty eight patients (94.4%) were women and age at diagnosis was 43.5+/-12.6 yr old (mean+/-SD). Thirty nine patients (54.2%) had a diffuse type of SSc. There were no statistical differences in the frequencies of all ACE I/D genotypes and D allele between patients and controls, and neither between diffuse and limited types of SSc. ACE I/D gene polymorphism was not associated with the development of SSc in Korea. The investigation for the pathogenesis of SSc requires more studies about the role of other candidate genes such as endothelin, TGF-beta, nitric oxide, or angiotensin II receptor in addition to the ACE genes.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Systemic sclerosis (SSc) is a systemic autoimmune disease of unknown etiology, characterized by microcirculatory dysfunction and accumulation of excessive extracellular matrices. Among suggested mechanisms, endothelial derangement is important in the pathogenesis of SSc, resulting in some features of vasculopathy such as Raynaud phenomenon and pulmonary hypertension (1).
###end p 3
###begin p 4
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 205 210 <span type="species:ncbi:9606">human</span>
Vascular injury is associated with increased local production of angiotensin-converting enzyme (ACE) and angiotensin II (2). ACE is a key enzyme in renin-angiotensin system (RAS) and widely distributed in human tissues including the lung, vascular endothelium, kidney, heart, and testes (3). ACE converts angiotensin I to angiotensin II, and inactivates bradykinin through the kallikrein-kininogen system. Angiotensin II may play a role in vascular diseases through vascular smooth muscle cell contraction and proliferation, monocyte adhesion, platelet aggregation, mediated either directly or via various factors such as endothelin, nitric oxide, and prostacyclin (4, 5).
###end p 4
###begin p 5
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
The ACE gene is located in the long arm of chromosome 17 (17q 23), and an insertion/deletion (I/D) polymorphism, determined by the presence or absence of a 287 base pair (bp) Alu repeat within intron 16, was identified (6). The DD genotype has about two-fold higher serum level of ACE than the II genotype, and the ID genotype has intermediate level (7). The DD genotype was associated with endothelial dysfunction, blunting the stimulated endothelial or donated nitric oxide response in normal population (8). Some epidemiologic studies have found that the D allele was associated with increased cardiovascular and renal risk (9).
###end p 5
###begin p 6
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
The association of ACE I/D genes has been studied in other rheumatic diseases with vascular involvement, and showed inconsistent data in systemic lupus erythematosus (3, 10), association of II genotypes in Kawasaki disease with coronary aneurysm (11), and irrelevance in Korean Behcet's disease (12).
###end p 6
###begin p 7
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Although ACE D genotype was reported as a risk factor of SSc in Italian (13), it has not been evaluated in other ethnic groups. We studied the association of ACE I/D genotypes with the development and clinical features of SSc in Korean.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin p 9
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 25 30 <span type="species:ncbi:9606">women</span>
###xml 34 37 <span type="species:ncbi:9606">men</span>
###xml 254 259 <span type="species:ncbi:9606">women</span>
###xml 264 267 <span type="species:ncbi:9606">men</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
###xml 782 789 <span type="species:ncbi:9606">patient</span>
Seventy two patients (68 women, 4 men) with SSc fulfilling the criteria proposed by the American College of Rheumatology (14) were enrolled. The age at diagnosis was 43.5+/-12.6 yr old (mean+/-SD). The controls were 114 healthy, disease free Koreans (41 women, 73 men). The age at enrollment was 37.2+/-4.6 yr old. The medical records of patients were reviewed retrospectively to collect clinical and laboratory data at the time of diagnosis and follow up. Anti-topoisomerase I autoantibody (Anti-topo I) was measured by double immunodiffusion (Immunothink, Seoul, Korea) and anti-centromere autoantibody (ACA) by a characteristic discrete speckled nuclear staining pattern on indirect immunofluorescent stains using IT-1 cell (Immunothink, Seoul, Korea). For ACE genotyping, every patient's genomic DNA was isolated from peripheral blood (Puregene kit, Gentra systems, Minneapolis, MN, U.S.A.) after getting the written informed consent.
###end p 9
###begin title 10
ACE I/D genotype determination
###end title 10
###begin p 11
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 896 898 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1051 1053 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1293 1295 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
ACE I/D genotype was determined by PCR method using oligonucleotides (sense 5'CTGGAGACCACTCCCATCCTTTCT 3', and antisense 5'GATGTGGCCATCACATTCGTCAGAT 3'). The reaction was carried out using 250 ng of genomic DNA, 10 mM Tris-HCl, 50 mM KCl, 3 mM MgCl2, 0.5 mM of each dNTP, and 1 unit of Taq DNA polymerase (Boehringer Mannheim, Germany) at a final volume of 40 microL under the following conditions: 30 cycles of denaturation at 94℃ for 1 min, annealing at 58℃ for 1 min, and extension at 72℃ for 2 min by Gene Amp system 9600 (Perkin Elmer Biosystem, Norwalk, CT, U.S.A.). The PCR products (190 and 490 bp) were electrophoresed on ethidium bromide stained 2% agarose gel and visualized under UV transilluminator (GelDoc 2000, Bio-Rad, CA, U.S.A.). On electrophoresis, ACE genotype I/I showed a 490 bp band, genotype D/D showed a 190 bp band, and I/D genotype showed both of 490 and 190 bp bands (10). We tried to confirm the genotypes by modification of PCR; annealing temperature at 60℃, and addition of the 5% dimethylsulfoxide in reaction mixture (15). In addition, each DD genotype was subjected to a PCR with primer pair that recognizes an insertion specific sequence using same PCR condition with first PCR, except an annealing temperatue of 67℃ to reduce overestimation of DD genotype (15).
###end p 11
###begin title 12
Statistical analysis
###end title 12
###begin p 13
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The chi-square test was used for comparison of nonparametric data and Fisher's exact test was used when the number was small. For comparison of parametric data, Student's t-test was used. The p-value lower than 0.05 (two-tailed) was considered statistically significant. We employed SPSS for Windows version 11.0.
###end p 13
###begin title 14
RESULTS
###end title 14
###begin title 15
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of patients with SSc
###end title 15
###begin p 16
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
###xml 312 320 <span type="species:ncbi:9606">patients</span>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
All patients had Raynaud phenomenon and the other manifestations were sclerodactyly (87.5%), digital pitting scar (47.2%), distal phalangeal resorption (29.2%), telangiectasia (25.0%), and subcutaneous calcinosis (5.6%). Interstitial lung disease was found in 37 patients (51.4%). Anti-topo I was positive in 15 patients (20.8%) and ACA in 4 patients (5.6%) (Table 1).
###end p 16
###begin p 17
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 274 281 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
The diffuse type of SSc was observed in 39 patients (54.2 %), showing more digital pitting scar (odds ratio [OR]=2.875, 95% confidence interval [95% CI]: 1.095-7.545, p=0.030) and distal phalangeal resorption (OR=5.602, 95% CI: 1.651-19.015, p=0.004) than the limited type (Table 1).
###end p 17
###begin title 18
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Distribution of ACE I/D genotypes in patients with SSc and controls
###end title 18
###begin p 19
###xml 147 154 147 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
The frequencies of II, ID, and DD genotypes were 45.8%, 44.5%, and 9.7% in patients, and 34.2%, 50.0%, and 15.8% in normal controls, respectively (Table 2). Also the frequency of D allele was 0.32 in patients, and 0.41 in normal controls. There was no significant difference in the distribution of genotypes and alleles between patients and controls. In addition there was no important difference in the gene frequency between diffuse and limited types of SSc.
###end p 19
###begin title 20
ACE I/D genotypes and clinical features of SSc
###end title 20
###begin p 21
There was no significant difference in the frequency of D allele according to the presence of individual clinical parameters of SSc (data not shown).
###end p 21
###begin title 22
DISCUSSION
###end title 22
###begin p 23
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
The main pathology of SSc is endothelial dysfunction. Higher ACE levels, related to the ACE D allele, may promote the production of angiotensin II and the degradation of bradykinin (16). However the ACE activity, which has been reported in SSc, was rather lower than normal even in those patients with very early disease, and without pulmonary hypertension resulting from endothelial dysfunction by chronic injury (17).
###end p 23
###begin p 24
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 523 531 <span type="species:ncbi:9606">patients</span>
###xml 838 843 <span type="species:ncbi:9606">women</span>
###xml 892 900 <span type="species:ncbi:9606">patients</span>
###xml 1294 1302 <span type="species:ncbi:9606">patients</span>
###xml 1436 1444 <span type="species:ncbi:9606">patients</span>
ACE I/D genotypes in 73 Italian patients with SSc and 112 controls showed that ACE D allele was associated with an increased risk of SSc, but not with the clinical features and disease subsets (13). In contrast, we did not find an association of ACE I/D genotypes with Korean SSc. The diffuse type of SSc showed more digital pitting scar and distal phalangeal resorption than limited type, but the distribution of ACE I/D genotypes was not different between both types. When we compared the frequencies of genotypes in SSc patients between Italian data (13) and ours, the frequency of D allele and DD genotype was much lower in this study (32% vs. 64% for D allele, and 9.7% vs. 38% for DD genotype). The exact reason why two studies showed different result requires more careful evaluation. Compared with Italian data (13), we have more women (94% vs. 85%) and younger (mean age, 44 vs. 62) patients. Although, it is still uncertain whether demographic discrepancy such as age or female predominance may influence the distribution of ACE I/D genes, there was no meaningful difference of gene frequency between Korean and Italian controls despite different sex and age ratios. The frequency of DD genotype, linked to higher ACE level in normal, was lower than the other genotypes in Korean SSc patients, but the difference did not show statistical significance. The exact correlation between ACE I/D genotype and serum levels of ACE in patients with SSc has not been performed yet. The exact reason of this discrepancy in the association with SSc is still unclear, and the racial differences in the genetic background, or interaction between genes controlling vascular tone may play a role.
###end p 24
###begin p 25
In conclusion, the ACE I/D polymorphism was not associated with the development of SSc in Korea. The genetic susceptibility in SSc needs more studies about the role of the other candidate genes such as endothelin-1, endothelin receptor, TGF-beta, nitric oxide, or angiotensin II receptor, in addition to the ACE genes.
###end p 25
###begin article-title 26
Systemic sclerosis: a vascular perspective
###end article-title 26
###begin article-title 27
Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis
###end article-title 27
###begin article-title 28
Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus
###end article-title 28
###begin article-title 29
Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis
###end article-title 29
###begin article-title 30
Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease
###end article-title 30
###begin article-title 31
###xml 60 65 <span type="species:ncbi:9606">human</span>
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
###end article-title 31
###begin article-title 32
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
###end article-title 32
###begin article-title 33
###xml 104 110 <span type="species:ncbi:9606">humans</span>
DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans
###end article-title 33
###begin article-title 34
###xml 106 112 <span type="species:ncbi:9606">humans</span>
The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans
###end article-title 34
###begin article-title 35
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE
###end article-title 35
###begin article-title 36
###xml 82 90 <span type="species:ncbi:9606">patients</span>
High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm
###end article-title 36
###begin article-title 37
Lack of association between angiotensin converting enzyme polymorphism and Korean Behcet's disease
###end article-title 37
###begin article-title 38
###xml 125 133 <span type="species:ncbi:9606">patients</span>
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis
###end article-title 38
###begin article-title 39
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
###end article-title 39
###begin article-title 40
Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis
###end article-title 40
###begin article-title 41
Stimulation of tissue-type plasminogen activator in vivo by infusion of bradykinin
###end article-title 41
###begin article-title 42
Pulmonary capillary endothelial dysfunction in early systemic sclerosis
###end article-title 42
###begin p 43
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Clinical characteristics in patients with systemic sclerosis (SSc)
###end p 43
###begin p 44
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 66 72 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 103 104 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Diffuse vs. limited SSc. *OR=2.875, 95% CI: 1.095-7.545, p=0.030. daggerOR=5.602, 95%CI: 1.651-19.015, p=0.004.
###end p 44
###begin p 45
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Distribution of ACE I/D genotypes between patients with systemic sclerosis (SSc) and controls
###end p 45
###begin p 46
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 80 86 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 114 115 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 128 141 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 183 195 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 228 229 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
SSc vs. Controls. *II genotype compared with ID and DD genotypes, p corr=0.226. daggerID compared with II and DD, p corr=0.920. double daggerDD compared with II and ID, p corr=0.474. section signD allele compared with I allele, p=0.186. ACE, angiotensin-converting enzyme.
###end p 46

